| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1432-1033.1990.TB15548.X |
| P698 | PubMed publication ID | 2163835 |
| P50 | author | Stefan Rose-John | Q47812749 |
| P2093 | author name string | T Kishimoto | |
| T Hirano | |||
| P C Heinrich | |||
| H Schmitz | |||
| E Hipp | |||
| G Dufhues | |||
| H Schooltink | |||
| X Schiel | |||
| D Lenz | |||
| P2860 | cites work | Production of hybridoma growth factor by human monocytes. | Q52827130 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | interleukins | Q194908 |
| P304 | page(s) | 79-83 | |
| P577 | publication date | 1990-05-01 | |
| P1433 | published in | FEBS Journal | Q1388041 |
| P1476 | title | Studies on the structure and regulation of the human hepatic interleukin-6 receptor | |
| P478 | volume | 190 |
| Q62658923 | A bioactive designer cytokine for human hematopoietic progenitor cell expansion |
| Q70524242 | Absence of expression of interleukin-6 (IL-6) mRNA in regenerating rat liver |
| Q41322816 | Acute phase proteins and transformed cells. |
| Q97646424 | Association of pro-inflammatory soluble cytokine receptors early during hepatocellular carcinoma stereotactic radiotherapy with liver toxicity |
| Q23920926 | Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease |
| Q37492314 | Cellular senescence or EGFR signaling induces Interleukin 6 (IL-6) receptor expression controlled by mammalian target of rapamycin (mTOR). |
| Q37370188 | Differential regulation of interleukin-6 receptor and gp130 gene expression in rat hepatocytes |
| Q78074203 | Effects of IL-6 and its soluble receptor on proteoglycan synthesis and NO release by human articular chondrocytes: comparison with IL-1. Modulation by dexamethasone |
| Q42947751 | Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sIL-6R double transgenic mice |
| Q26738992 | Generation of Soluble Interleukin-11 and Interleukin-6 Receptors: A Crucial Function for Proteases during Inflammation |
| Q59329194 | IL-23R Signaling Plays No Role in Myocardial Infarction |
| Q38241232 | IL-6 biology: implications for clinical targeting in rheumatic disease |
| Q38058509 | IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. |
| Q36649092 | Inhibition of IL-6+IL-6 soluble receptor-stimulated aromatase activity by the IL-6 antagonist, Sant 7, in breast tissue-derived fibroblasts |
| Q36495258 | Interleukin-6 and its receptor: from bench to bedside |
| Q40850225 | Interleukin-6 in biology and medicine |
| Q37189514 | Interleukin-6 in clinical medicine |
| Q35780414 | Mediators of the Jak/STAT signaling pathway in human spermatozoa |
| Q36031506 | Modulation of the IL-6 Receptor α Underlies GLI2-Mediated Regulation of Ig Secretion in Waldenström Macroglobulinemia Cells. |
| Q42159470 | Oncostatin M, leukaemia-inhibitory factor and interleukin 6 trigger different effects on alpha1-proteinase inhibitor synthesis in human lung-derived epithelial cells |
| Q77648514 | Peptide inhibition of cytokine-stimulated aromatase activity in breast tissue fibroblasts |
| Q41560071 | Pharmacological approaches and strategies for therapeutic modulation of fibrinogen |
| Q41466700 | Regulation of interleukin-6 receptor expression by interleukin-6 in human monocytes--a re-examination |
| Q95276341 | SARS-CoV-2 and COVID-19: is interleukin-6 (IL-6) the 'culprit lesion' of ARDS onset? What is there besides Tocilizumab? SGP130Fc |
| Q42817997 | Soluble human interleukin-6-receptor modulates interleukin-6-dependent N-glycosylation of alpha 1-protease inhibitor secreted by HepG2 cells |
| Q41321485 | Soluble interleukin-6 receptor strongly increases the production of acute-phase protein by hepatoma cells but exerts minimal changes on human primary hepatocytes |
| Q44694693 | Stimulation of CRP secretion in HepG2 cells: Cooperative effect of dexamethasone and interleukin 6 |
| Q24529580 | Structural and functional studies on the human hepatic interleukin-6 receptor. Molecular cloning and overexpression in HepG2 cells |
| Q40147932 | The Soluble Interleukin 6 Receptor: Advanced Therapeutic Options in Inflammation |
| Q41601153 | The human hepatoma Hep3B cell line as an experimental model in the study of the long-term regulation of acute-phase proteins by cytokines |
| Q34991808 | The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex |
| Q41575411 | The soluble interleukin-6 receptor is generated by shedding |
| Q33630767 | The stressful condition as a nutritionally dependent adaptive dichotomy |
| Q41640170 | Up-regulation of the interleukin-6-signal transducing protein (gp130) by interleukin-6 and dexamethasone in HepG2 cells |
Search more.